MALINA RUIZ: Open Payments
NPI 1417556705 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 13 payments from 8 companies in 2025. Trend: 2023 $392 · 2024 $527 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $148 |
| Novo Nordisk Inc | 1 | $111 |
| Braeburn Inc. | 1 | $96 |
| Amgen Inc. | 3 | $94 |
| ABBVIE INC. | 3 | $81 |
| SANOFI PASTEUR INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Epclusa, Ozempic, BRIXADI, KRYSTEXXA, VRAYLAR, BEYFORTUS, JARDIANCE, ROTATEQ.
Industry payments across NV — which companies pay providers there.
